Parkinsons Disease Clinical Trials 2024

Parkinsons Disease Clinical Trials 2024

Parkinsons Disease research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in parkinsons disease clinical trials today.

Parkinsons Disease Clinical Trials

Here are the 0 most popular medical studies for parkinsons disease

Popular filter options for parkinsons disease trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to parkinsons disease

What are the top hospitals conducting parkinsons disease research?

In the quest to find effective treatments and potential cures for [Parkinson's disease]('s-disease), dedicated hospitals are leading the way in clinical trials. Sunybrook Research Institute in Toronto, known for its cutting-edge research, is currently conducting one active trial focused on Parkinson's disease. This renowned institution serves as a beacon of hope for patients seeking innovative interventions for this neurological condition. Similarly, UC San Diego in La Jolla is making strides with their own ongoing trial dedicated to Parkinson's disease. As a hub of medical excellence and groundbreaking research, this hospital plays a crucial role in advancing our understanding of this complex disorder.

Meanwhile, Renstar Medical Research in Ocala has taken up the challenge with an active clinical trial focusing on Parkinson's disease as well. In collaboration with skilled researchers and healthcare professionals, they strive to uncover new possibilities that can improve the lives of those affected by this debilitating condition. Raleigh Neurology Associates also joins the ranks by actively engaging in a clinical trial targeting Parkinson's disease. Their commitment to finding better treatment options demonstrates their dedication towards providing comprehensive care within their community.

Toronto Western Hospital stands tall among these esteemed institutions by spearheading yet another active clinical trial centered around Parkinson's disease. Located within Toronto’s vibrant medical landscape and backed by renowned experts, this hospital showcases its unwavering determination to combatting neurodegenerative disorders such as Parkinson’s.

While all five hospitals proudly focus their efforts on current trials related to Parkinson’s disease treatment or management strategies; it is important to note that specific numbers tied exclusively only towards projects mentioned here reflect solely at present state - other successful contributions might have been overlooked due lack statistical data corresponding earlier stages conducted there individually before further updates made publicly available

These hospitals serve as beacons of hope for those living with Parkinson’s disease and exemplify collective dedication toward unraveling its mysteries through innovative research initiatives.

Which are the best cities for parkinsons disease clinical trials?

In the realm of [Parkinson's disease]('s-disease) clinical trials, several cities emerge as focal points for research and advancements. Toronto, Ontario leads the pack with 2 active trials investigating various aspects of the disease, including Idiopathic PD Patients and Prasinezumab. La Jolla in California, Ocala in Florida, Raleigh in North carolina, and Augusta in Georgia each have 1 active trial focusing on treatments like Prasinezumab and other interventions. These cities provide individuals with Parkinson's disease access to cutting-edge clinical trials that aim to improve understanding and treatment options for this complex condition.

Which are the top treatments for parkinsons disease being explored in clinical trials?

Clinical trials are paving the way for advancements in [Parkinson's disease]('s-disease) treatment. Among the top treatments being explored, three stand out:

  • Gene therapies: Focused on modifying genes to alleviate symptoms and slow progression.
  • Deep brain stimulation (DBS): Using electrodes implanted in the brain to regulate abnormal activity and improve motor functions.
  • Immunotherapies: Harnessing the power of the immune system to target and clear toxic proteins associated with Parkinson's. With ongoing research, these treatments offer hope for improved management and quality of life for individuals with Parkinson's disease.
What are the most recent clinical trials for parkinsons disease?

Exciting developments are underway in the field of [Parkinson's disease]('s-disease) research, with recent clinical trials offering promising prospects for patients. One notable trial focuses on prasinezumab, a potential treatment option currently in Phase 2 testing for individuals with Parkinson's disease. This novel therapy is expected to target specific protein abnormalities associated with the condition, aiming to slow down its progression and improve symptom management. With ongoing advancements like these, there is renewed hope for those living with Parkinson's disease and their loved ones.

What parkinsons disease clinical trials were recently completed?

Several recent clinical trials for [Parkinson's disease]('s-disease) have reached important milestones, demonstrating ongoing efforts to advance treatments for this neurodegenerative condition. Notably, a trial sponsored by the Michael J. Fox Foundation investigated the effectiveness of an experimental therapy and concluded in November 2021. In addition, a study conducted by the National Institutes of Health evaluating the safety and efficacy of a potential treatment was completed in October 2021. These significant achievements highlight continued progress in Parkinson's research and offer hope for improved management strategies for individuals living with this challenging disease.